(Q39224072)

10 September 2017

Drug response and psychiatric nosology (English)

1 reference

10 September 2017

Robin M. Murray

1

0 references

author name string

Murray RM

series ordinal

1

1 reference

10 September 2017

Murphy DL

series ordinal

2

1 reference

10 September 2017

Dennis L. Murphy

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 November 1978

1 reference

10 September 2017

November 1978

0 references

published in

Psychological Medicine

1 reference

10 September 2017

8

1 reference

10 September 2017

4

1 reference

10 September 2017

04

0 references

page(s)

667-681

1 reference

Diagnostic Criteria for Use in Psychiatric Research

10 September 2017

667

0 references

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

An Attempt at Validation of Traditional Psychiatric Syndromes by Cluster Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

5-Hydroxytryptamine and dopamine pathways in mania: a pilot study of fenfluramine and pimozide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Newer concepts of psychiatric diagnosis and biochemical research on mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Toward a taxonomy of psychopathology: the purpose of psychiatric classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Prediction of tricyclic antidepressant response: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Assessing Clinical Characteristics of the Manic State

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

A Comparison of Antidepressant Medications in Neurotic and Psychotic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Importance of dopamine metabolism for clinical effects and side effects of neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Towards Rational Therapy with Monoamine Oxidase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Acute mania. Clinical and genetic study of responders and nonresponders to treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Lithium responders: an evaluation of psychological test characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

L-Dopa, Dopamine, and Hypomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

A prospective study of the influence of post-graduate training in psychiatry on the rating of mental abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

The Effect of Lithium Carbonate on Affect, Mood, and Personality of Normal Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Acetylator status and response to phenelzine in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

MMPI delineation of a subgroup of depressed patients refractory to lithium carbonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Reliability of psychiatric diagnosis. I. A methodological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Lithium Response in Unipolar Versus Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

The effect of lithium on impulsive aggressive behavior in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

The treatment of manic psychoses by the administration of lithium salts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Lithium in psychiatric therapy and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

A Clinical Trial of Phenelzine in Anxiety Depressive and Phobic Neuroses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Effects of mode of management on plasma chlorpromazine in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Plasma-hydrocortisone response to ethanol in chronic alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Lithium in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Amitriptyline in Anxious-Depressed Outpatients: A Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Schizo-affective psychosis: fact or fiction? A survey of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Catecholamine Metabolism, Depressive Illness, and Drug Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

21 January 2018

Fenfluramine in mania.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Depressive Typologies and Response to Amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Beta-endorphin--induced changes in schizophrenic and depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

Drug refusal in schizophrenia and the wish to be crazy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Two dosages of imipramine in hospitalized endogenous and neurotic depressives

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

The classification of psychotropic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Prediction of response to chlorpromazine treatment in schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

A CONTROLLED TRIAL OF IMIPRAMINE

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

DIFFERENT POPULATIONS, DIFFERENT DRUG RESPONSES. A COMPARATIVE STUDY OF TWO ANTI-DEPRESSANTS, EACH USED IN TWO DIFFERENT PATIENT GROUPS

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Lithium prophylaxis in recurrent affective illness

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Drugs, neurotransmitters, and schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Classification of Depressed Patients: A Cluster Analysis Derived Grouping

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Differentiation of two genetically specific types of depression by the response to antidepressant drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Depression, elation, and lithium carbonate responses in manic patient subgroups

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

The Behavioral Toxicity of Monoamine Oxidase-lnhibiting Antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Amine Precursors and Depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Relationship between the effectiveness of lithium therapy and family history

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

A controlled study of the antidepressant effects of lithium carbonate

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Prediction of Improvement in Schizophrenia Under Four Phenothiazines

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim report

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Relationship between plasma level and therapeutic effect of nortriptyline.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

l-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Psychiatric diagnosis and a typology of clinical drug effects

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Erythrocyte membrane cation carrier, relapse rate of manic-depressive illness and response to lithium

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Urinary dimethyltryptamine and psychiatric symptomatology and classification

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

"Lithium non-responders" in a lithium clinic

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Phenelzine in phobic anxiety: a controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Predicting individual responses to drug treatment in schizophrenia: a test dose model

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Unipolar and bipolar depressive illness. Phenomenology and response to electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Comparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic States

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Lithium carbonate prophylaxis failure

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Frequency of diagnoses of schizophrenia versus affective disorders from 1944 to 1968

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Prediction of response to phenothiazines in schizophrenia. A crossvalidation study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Intracellular lithium concentration and clinical response: towards a membrane theory of depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

A controlled trial of fructose in the treatment of acute alcoholic intoxication

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Nosology of depression and differential response to drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

The Reliability of Psychiatric Diagnosis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Depression, Delusions, and Drug Response

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Trends in the frequency of schizophrenia by different diagnostic criteria

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Prediction of drug effect in personality disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Specific indications for different classes of phenothiazines

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

A comparative trial of four monoamine oxidase inhibitors on chronic depressives

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Comparison of antidepressant drugs in depressive illnesses

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Predicting response to phenothiazines: the right drug for the right patient

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

CHANGES IN SCHIZOPHRENIC PSYCHOPATHOLOGY AND WARD BEHAVIOUR AS A FUNCTION OF PHENOTHIAZINE TREATMENT

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

The reliability of clinical methods, data and judgments (first of two parts)

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

On certain psychopharmacological and physiological differences between schizophrenic and normal persons

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

Trial of Maintenance Therapy in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700018870

7 January 2021

10.1017/S0033291700018870

Identifiers

DOI

0 references

1 reference